2Azido-GLFDIIKKIAESF-OH

Ref. 3D-PP47456

Informations sur le produit

• Nom: 2Azido-GLFDIIKKIAESF-OH

Description

Peptide 2Azido-GLFDIIKKIAESF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 2Azido-GLFDIIKKIAESF-OH include the following: Protein Based Technologies to Identify, Study, and Control Intracellular Processes VJ Bruce - 2017 - search.proquest.comhttps://search.proquest.com/openview/bbba6c77b071dcc0c07af1710cd2b96c/1?pq-origsite=gscholar&cbl=18750 Design of polymeric carriers for intracellular peptide delivery in oncology applications S Lv , M Sylvestre, AN Prossnitz , LF Yang - Chemical , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.chemrev.0c00963 Design and characterization of new antimicrobial peptides derived from aurein 1.2 with enhanced antibacterial activity M Ramezanzadeh, N Saeedi, E Mesbahfar, P Farrokh - Biochimie, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908420303084 Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo M Li, Y Tao, Y Shu, JR LaRochelle - Journal of the , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.5b05694 Designing potent anticancer peptides by Aurein 1.2 key residues mutation and catenate cell-penetrating peptide HS Garnaie, A Shahabi , MH Geranmayeh - Advanced , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460806/ How to overcome endosomal entrapment of cell-penetrating peptides to release the therapeutic potential of peptides? F Nadal-Bufaca­ , ST Henriques - Peptide Science, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pep2.24168 Peptide-Based Strategies of Delivering Semiconductor Nanocrystals into Living Cells CIR Vera - 2017 - indigo.uic.eduhttps://indigo.uic.edu/articles/thesis/Peptide-Based_Strategies_of_Delivering_Semiconductor_Nanocrystals_into_Living_Cells/10950494/files/19444094.pdf Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro A Biabangard, A Asoodeh , MR Jaafari - Expert opinion on drug , 2022 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/17425247.2022.2147505

• Marque: Biosynth